1. Home
  2. GKOS vs OSK Comparison

GKOS vs OSK Comparison

Compare GKOS & OSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • OSK
  • Stock Information
  • Founded
  • GKOS 1998
  • OSK 1917
  • Country
  • GKOS United States
  • OSK United States
  • Employees
  • GKOS N/A
  • OSK N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • OSK Auto Manufacturing
  • Sector
  • GKOS Health Care
  • OSK Consumer Discretionary
  • Exchange
  • GKOS Nasdaq
  • OSK Nasdaq
  • Market Cap
  • GKOS 8.4B
  • OSK 7.3B
  • IPO Year
  • GKOS 2015
  • OSK N/A
  • Fundamental
  • Price
  • GKOS $102.04
  • OSK $94.32
  • Analyst Decision
  • GKOS Strong Buy
  • OSK Buy
  • Analyst Count
  • GKOS 13
  • OSK 14
  • Target Price
  • GKOS $161.54
  • OSK $125.50
  • AVG Volume (30 Days)
  • GKOS 1.0M
  • OSK 815.8K
  • Earning Date
  • GKOS 04-30-2025
  • OSK 04-24-2025
  • Dividend Yield
  • GKOS N/A
  • OSK 2.16%
  • EPS Growth
  • GKOS N/A
  • OSK 13.99
  • EPS
  • GKOS N/A
  • OSK 10.35
  • Revenue
  • GKOS $383,481,000.00
  • OSK $10,730,200,000.00
  • Revenue This Year
  • GKOS $27.84
  • OSK N/A
  • Revenue Next Year
  • GKOS $27.99
  • OSK $5.19
  • P/E Ratio
  • GKOS N/A
  • OSK $9.11
  • Revenue Growth
  • GKOS 21.85
  • OSK 11.10
  • 52 Week Low
  • GKOS $88.16
  • OSK $89.08
  • 52 Week High
  • GKOS $163.71
  • OSK $127.98
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 37.88
  • OSK 38.79
  • Support Level
  • GKOS $98.03
  • OSK $94.16
  • Resistance Level
  • GKOS $108.62
  • OSK $100.03
  • Average True Range (ATR)
  • GKOS 3.96
  • OSK 2.36
  • MACD
  • GKOS 1.87
  • OSK 0.16
  • Stochastic Oscillator
  • GKOS 47.86
  • OSK 18.66

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.

About OSK Oshkosh Corporation (Holding Company)Common Stock

Oshkosh is the top producer of access equipment, specialty vehicles, and military trucks. It serves diverse end markets, where it is typically the market share leader in North America, or, in the case of JLG aerial work platforms, a global leader. The company had manufactured joint light tactical vehicles for the us Department of Defense. However, Oshkosh recently lost the JLTV recompete, bringing into focus its us Postal Service contract, which calls for the electrification of us postal vehicles. The company reports in three segments—access equipment (52% of revenue), defense (22%), and vocational (27%)—and generated $9.6 billion in revenue in 2023.

Share on Social Networks: